Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors
Clinical trial NCT05262530 · TERMINATED
Trial details
- NCT number
- NCT05262530
- Sponsor
- BioNTech SE
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-22
- Primary completion
- 2025-12-22
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.